Back to search

Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen

Data up to Jan 2025

Published1981
Citations197
References44

Total Citations Per Year

Abstract

References (44)

Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease

1971 • 2,055 citations

RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES

1969 • 623 citations

The Familial Hyperlipoproteinemias

1975 • 538 citations

Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia

1974 • 480 citations

Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.

1971 • 404 citations

High Density Lipoprotein Metabolism in Man

1977 • 404 citations

Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism

1980 • 357 citations

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

1979 • 254 citations

Biochemical site of regulation of bile acid biosynthesis in the rat

1970 • 250 citations

Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia

1977 • 241 citations

Dietary and Drug Treatment of Primary Hyperlipoproteinemia

1972 • 185 citations

The LDL Pathway in Human Fibroblasts: A Receptor-Mediated Mechanism for the Regulation of Cholesterol Metabolism

1976 • 183 citations

CLINICAL AND METABOLIC EFFECTS OF DIFFERENT DOSES OF PROSTAGLANDIN E1 IN MAN

1968 • 161 citations

Coronary Disease in Familial Hypercholesterolemia

1967 • 123 citations

Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins.

1976 • 117 citations

Familial hypercholesterolemia

1975 • 113 citations

THE DETERMINATION OF N-METHYL-2-PYRIDONE-5-CARBOXAMIDE IN HUMAN URINE

1954 • 96 citations

Lipoproteins and Lipid Transport

1975 • 96 citations

Mechanism of the Hypolipemic Effect of Clofibrate in Postabsorptive Man

1973 • 90 citations

Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.

1977 • 78 citations

Effects of Neomycin Alone and in Combination with Cholestyramine on Serum Cholesterol and Fecal Steroids in Hypercholesterolemic Subjects

1979 • 77 citations

Hypolipidemic Drugs and Lipoprotein Metabolism

1972 • 71 citations

Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins

1979 • 68 citations

The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.

1969 • 63 citations

Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.

1973 • 61 citations

Failure of Complete Bile Diversion and Oral Bile Acid Therapy in the Treatment of Homozygous Familial Hypercholesterolemia

1977 • 56 citations

The Effects of Colestipol Resin and of Colestipol Plus Clofibrate on the Turnover of Plasma Cholesterol in Man

1973 • 54 citations

Cholestyramine and ileal by‐pass in the treatment of familial hypercholesterolaemia

1977 • 53 citations

Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form

1971 • 52 citations

The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia

1977 • 46 citations

Effect of nicotinic acid on catabolism and synthesis of cholesterol in man

1968 • 43 citations

Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate

1970 • 34 citations

Mechanisms of hypolipidemic action of nicotinic acid

1978 • 33 citations

Influence of Indomethacin on Flush Induced by Nicotinic Acid in Man

1977 • 31 citations

Xeroradiographic techniques applied to assessment of Achilles tendon in inflammatory or metabolic diseases.

1975 • 30 citations

The Effect of Nicotinic Acid Treatment on the Chemical Composition of Plasma Lipoprotein Classes in Man

1969 • 30 citations

Methods for the determination of N-methyl-2-pyridone-5-carboxylamide and of N-methyl-2-pyridone-3-carboxylamide in human urine

1949 • 24 citations

Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.

1977 • 23 citations

Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.

1975 • 21 citations

Nicotinic Acid and Inhibition of Fat Mobilizing Lipolysis. Present Status of Effects on Lipid Metabolism

1978 • 20 citations

Colestipol in familial type II hyperlipoproteinemia: A three‐year trial

1976 • 19 citations

The effect of nicotinic acid on the metabolism of the plasma lipoproteins of rhesus monkeys

1975 • 19 citations

EFFECTS AND SIDE‐EFFECTS OF TREATMENT OF HYPERCHOLESTEROLEMIA WITH CHOLESTYRAMINE AND NEOMYCIN

1973 • 11 citations

Clofibrate in Type II Hyperlipoproteinemia

1976 • 3 citations

Cited By (0)

No citing papers found in database

Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial… (1981) – New England Journal of Medicine | Metascience Observatory Explorer